MEDICA 2024 + COMPAMED 2024: Adapted Hall Layout for Better Integration
|
By LabMedica International staff writers Posted on 23 Aug 2024 |

The final preparations for MEDICA 2024 and COMPAMED 2024 trade fairs organized by Messe Düsseldorf (Düsseldorf, Germany) have begun. A total of more than 6,000 participants from approximately 70 countries will fill the entire hall space on the trade fair premises, and their innovations will highlight both events’ place as globally unique information and business platforms serving the entire added-value chain of medical-technical systems and products – including manufacture and development (Düsseldorf, 11–14 November 2024).
In the MEDICA halls housing the worlds of experience “Med Tech & Devices” and “Digital Health”, professional visitors can now benefit from thematic hall space allocation and a new location for the accompanying German Hospital Conference. To date, the flagship event for top managers of German clinics was held at the Congress Center Düsseldorf; now it has been moved to the heart of the trade fair in Hall 12. All around the event area, exhibiting companies that fit the theme of the world of experience “Med Tech & Devices” will be grouped together with innovations for hospital equipment and operating theatres. “Digital Health” has now been placed just next door in Hall 13 including its themed stage program and the high-traffic special exhibitions, highlighting the advantages of theme-based synergistic effects and easy access for an efficient trade fair visit.
Hall 13 (also near the German Hospital Conference in Hall 12) offers its audience of medical experts the MEDICA ECON FORUM, organized by the Techniker Krankenkasse health insurance fund, that addresses current themes in healthcare policy (particularly regarding the digitalization of healthcare), the MEDICA INNOVATION FORUM (with its popular start-up pitches) and the special exhibitions “Hospital of the Future” (innovations on the topics of “Digital hospital infrastructure” and “Data usage exemplified by intensive care medicine”), the Wearable Technologies show and the MEDICA START-UP PARK as a hub for networking with the digitally based start-up scene. At MEDICA 2024, there are five worlds of experience promising a comprehensive range of innovations for the treatment of outpatients and clinical use. In the past two years, the database of companies and products at the MEDICA.de internet portal listed more than 12,000 innovations by exhibiting companies at the beginning of each trade fair. The trade fair’s worlds of experience are Lab & Diagnostics, Med Tech & Devices, Disposables, Physio Tech, and Digital Health.
Held in parallel to MEDICA as always, COMPAMED can look back on more than 30 years of success since its first event in 1992 and has become an absolute hotspot for complex high-tech solutions. About 750 exhibiting companies will present their specialized knowledge as manufacturers and suppliers at COMPAMED 2024, also in five worlds of experience: Manufacturing & Devices (e.g., components, parts, manufacturing processes), Services & Advice (e.g., research, development, services), Materials (e.g., plastics, glass, ceramics, metals, composite materials, adhesives, packaging), Micro Tech (such as micro components, microfluidics) as well as IT in Tech (software development and maintenance for medical technology).
Dominating market trends are currently causing a huge demand for information and plenty of issues for debate. MEDICA 2024 and COMPAMED 2024 will address them in their outstanding stage program and the accompanying forums and conferences. This year, the hot topics at MEDICA include the current examples of AI applications and robots and assistive systems in day-to-day medical practice. Another focus is on the increasing connectivity in healthcare provision, specifically on innovations for the point of care, which means diagnostics and treatment near patients (usually outpatients). This includes telemedical applications to provide optimized cooperation across all sectors by all persons involved in the treatment process.
Another top issue at this year’s MEDICA is the human factor. The urgent lack of skilled professionals also affects almost all companies active in healthcare, leading them to search for solutions. These topics will be discussed in individual forums and at conferences that are appropriate to each target group. For example, there are the MEDICA HEALTH IT FORUM (that deals with IT topics like big data, artificial intelligence and cyber security) and the new MEDICA INNOVATION FORUM. This forum will replace the former MEDICA CONNECTED HEALTHCARE FORUM. Because digital innovations are not limited to optimized connections between all healthcare players, the MEDICA INNOVATION FORUM will focus on the digital transformation of the healthcare industry in its entirety. The start-up competitions integrated into the forum program will shine a spotlight on fresh ideas and product solutions by young developer teams on the first two days of the trade fair.
COMPAMED also promises excitement, information, and open discussions. The agendas at the COMPAMED HIGH-TECH FORUM and COMPAMED SUPPLIERS FORUM reflect the top issues of the supply sector such as AI, robotics, and automation, new trends in microtechnology, and innovations in materials. The program is rounded out by contributions and discussions about the best practices of international market cultivation. Supply chain management, questions of product approval, and patent law are some of the relevant aspects. The trade fair booths and stages are not the only places where innovations will be presented and highlighted. Messe Düsseldorf’s new video podcast “Trade Talk Today” will also broadcast important updates on innovations and event highlights so that you can start every day of the trade fair on schedule. “Movers and shakers” grant insights and contextualize industry trends.
Related Links:
Messe Düsseldorf
Latest Industry News
- AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
- New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
- Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
- WHX Labs Dubai to Gather Global Experts in Antimicrobial Resistance at Inaugural AMR Leaders’ Summit
- BD and Penn Institute Collaborate to Advance Immunotherapy through Flow Cytometry
- Abbott Acquires Cancer-Screening Company Exact Sciences
- Roche and Freenome Collaborate to Develop Cancer Screening Tests
- Co-Diagnostics Forms New Business Unit to Develop AI-Powered Diagnostics
- Qiagen Acquires Single-Cell Omics Firm Parse Biosciences
- Puritan Medical Products Showcasing Innovation at AMP2025 in Boston
- Advanced Instruments Merged Under Nova Biomedical Name
- Bio-Rad and Biodesix Partner to Develop Droplet Digital PCR High Complexity Assays
- Hologic to be Acquired by Blackstone and TPG
- Bio-Techne and Oxford Nanopore to Accelerate Development of Genetics Portfolio
- Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders
- Revvity and Sanofi Collaborate on Program to Revolutionize Early Detection of Type 1 Diabetes
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more







